1. Home
  2. KVHI vs CRBU Comparison

KVHI vs CRBU Comparison

Compare KVHI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$9.33

Market Cap

177.2M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.45

Market Cap

145.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
CRBU
Founded
1978
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.2M
145.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
KVHI
CRBU
Price
$9.33
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
210.4K
1.7M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
3.64
EPS
0.03
N/A
Revenue
$9,622,000.00
N/A
Revenue This Year
$28.90
$1.63
Revenue Next Year
$31.85
$10.93
P/E Ratio
$309.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$1.38
52 Week High
$13.00
$3.53

Technical Indicators

Market Signals
Indicator
KVHI
CRBU
Relative Strength Index (RSI) 51.25 31.38
Support Level $8.72 $1.39
Resistance Level $9.41 $1.77
Average True Range (ATR) 0.41 0.08
MACD 0.01 -0.02
Stochastic Oscillator 68.23 3.80

Price Performance

Historical Comparison
KVHI
CRBU

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: